AU3923000A - Agp-1 fusion protein compositions and methods - Google Patents

Agp-1 fusion protein compositions and methods

Info

Publication number
AU3923000A
AU3923000A AU39230/00A AU3923000A AU3923000A AU 3923000 A AU3923000 A AU 3923000A AU 39230/00 A AU39230/00 A AU 39230/00A AU 3923000 A AU3923000 A AU 3923000A AU 3923000 A AU3923000 A AU 3923000A
Authority
AU
Australia
Prior art keywords
agp
methods
fusion protein
protein compositions
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39230/00A
Inventor
Hailing Hsu
Shi-Yuan Meng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AU3923000A publication Critical patent/AU3923000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
AU39230/00A 1999-04-16 2000-03-24 Agp-1 fusion protein compositions and methods Abandoned AU3923000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29324599A 1999-04-16 1999-04-16
US09293245 1999-04-16
PCT/US2000/008004 WO2000063253A1 (en) 1999-04-16 2000-03-24 Agp-1 fusion protein compositions and methods

Publications (1)

Publication Number Publication Date
AU3923000A true AU3923000A (en) 2000-11-02

Family

ID=23128307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39230/00A Abandoned AU3923000A (en) 1999-04-16 2000-03-24 Agp-1 fusion protein compositions and methods

Country Status (2)

Country Link
AU (1) AU3923000A (en)
WO (1) WO2000063253A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284236B1 (en) 1995-06-29 2001-09-04 Immunex Corporation Cytokine that induces apoptosis
EP1870464A3 (en) * 1999-06-02 2008-03-12 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
KR20030009522A (en) * 2000-06-13 2003-01-29 칠드런'즈 메디컬 센터 코포레이션 Biosynthetic oncolytic molecules and uses therefor
AU2002333502A1 (en) 2002-02-10 2003-09-04 Apoxis Sa Fusion constructs containing active sections of tnf ligands
EP1499347A2 (en) * 2002-03-15 2005-01-26 Department of Veterans Affairs, Rehabilitation R&D Service Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
AU2003233008B2 (en) * 2002-04-22 2008-04-24 Recopharma Ab Fusion polypeptides and methods for inhibiting microbial adhesion
JP2007504144A (en) 2003-08-26 2007-03-01 ザ リージェンツ オブ ザ ユニバーシティー オブ コロラド ア ボディー コーポレイト Serine protease activity inhibitors and methods for their use in the treatment and composition of bacterial infections
WO2005077977A2 (en) 2004-02-11 2005-08-25 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Carcinoembryonic antigen fusions proteins and uses thereof
KR100888022B1 (en) 2006-12-21 2009-03-09 재단법인 목암생명공학연구소 Fusion Proteion of Imunoglobulin Fc and Human Apolipoproteina Kringle Fragment
CN103153332A (en) 2010-09-28 2013-06-12 卡尔医疗有限公司 Compositions and methods for treatment of hematological malignancies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101004174B1 (en) * 1995-06-29 2010-12-24 임뮤넥스 코포레이션 Cytokine that induces apoptosis
JP2000515727A (en) * 1996-06-07 2000-11-28 アムジエン・インコーポレーテツド Tumor necrosis factor-related polypeptide

Also Published As

Publication number Publication date
WO2000063253A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
AU6058500A (en) Fusion protein and uses thereof
AUPQ419099A0 (en) Novel compositions and methods
AU3562299A (en) Inhibin-hbc fusion protein
ZA9711239B (en) OB fusion protein compositions and methods.
AU2434199A (en) Protein
AU2001291049A1 (en) Defensin-antigen fusion proteins
HUP0104750A3 (en) Opg fusion protein compositions and methods
AU2349399A (en) R-lansoprazole compositions and methods
AU2880400A (en) Tnf-related proteins
GB9913437D0 (en) Fusion proteins
AU6232300A (en) Receptors and associated proteins
AU1608201A (en) Human zven proteins
AU3923000A (en) Agp-1 fusion protein compositions and methods
AU3020899A (en) Compositions and methods for protein secretion
AU1083501A (en) Antibiotic-metal complex and methods
AU2346800A (en) Compositions and methods using cell fusion
AU2136401A (en) P450rai-2 and related proteins
AU3890200A (en) Novel porcine protein and uses thereof
AU1881200A (en) Novel proteins
AU6983000A (en) Chimeric proteins
AU1477601A (en) Genetic compositions and methods
AU1540701A (en) Novel protein
AU6509899A (en) Odor-control methods and compositions
AU3411999A (en) Novel rnase-like protein and its use
AU2593199A (en) Human smn-like protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase